The fintech lending realm is not as uniformly secure as low unemployment figures might suggest. Lenders like SoFi, with prime-focused clients, exhibit resilience, while Upstart, dealing with subprime borrowers, faces...
The European Commission's recent push for a transatlantic trade deal is capturing market attention, with the "zero for zero" tariff proposal positioned as a potential game changer. Industrial sectors like...
Artificial intelligence is transforming healthcare investments into two distinct paths: tech disruptors like Hims & Hers and Oscar Health focus on user growth, while pharma giants Novo Nordisk and Eli...
Datadog's recent debut in the S&P 500 has propelled its stock upwards, driven by mechanical buying from passive index funds. This milestone, while validating its role in the cloud observability...
The recent surge in Vietnamese equities, with the VN-Index hitting a three-year high, offers an intriguing tale of economic complexity. While a 20% tariff on exports is better than the...
The U.S. and Vietnam trade agreement has sent stock markets soaring, signalling a major shift in global supply chains. This isn't merely a blip; it's a formal nod to the...
The battle between Berkshire Hathaway and ARK Invest is not merely about stock choices but a vivid representation of two differing worldviews. Berkshire leans towards economic continuity and strong cash...
A director's significant insider purchase has led to Bit Digital ($BTBT) shares rising over 30% in a week, sparking intrigue in the crypto mining world. The company's strategic pivot to...
In the ever-evolving world of biotechnology, Moderna and Regeneron represent two contrasting tales. Moderna's cash-rich strategy must pivot beyond its COVID-19 success to future profitability, battling market scepticism. Meanwhile, Regeneron's...
Amidst a storm of elevated medical costs, regulatory scrutiny, and an antitrust probe, UnitedHealth Group's valuation tumble in 2024 offers insights into market dynamics. Despite challenges, Q1 2024 saw an...
